# Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

> **NCT00028678** · PHASE2 · COMPLETED · sponsor: **Eastern Cooperative Oncology Group** · enrollment: 45 (actual)

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **DRUG:** dalteparin
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00028678
- **Lead sponsor:** Eastern Cooperative Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07-11
- **Primary completion:** 2006-07
- **Final completion:** 2007-06
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2023-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00028678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00028678, "Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00028678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*